EDGAR MOCANU: I'm Edgar
obstetrician and gynecologist at
the Rotunda Hospital in Dublin.
I'm also the European Society of
Human Reproduction and Embryology
EU TCD task force coordinator.
I'll be talking about the
regulation of assisted reproduction
under the European tissue
and cell directors.
I will specifically address
the objectives of introducing
regulation in this field and dissect
the three directives, which have
been transposed into law in European
countries. I would like to describe
the specific implications for member
states, for tissue establishments,
and for competent authorities.
From the beginning,
I would like to acknowledge
that ART services have no country
or continental borders at present.
Both patients and reproductive
materials like gametes, embryos,
and frozen issues liberally cross
borders, as do individuals that can
act both as recipients or donors.
This makes the
regulation and quality
assurance of reproductive
tourism a significant task.
From this perspective,
the European Commission
has introduced the
directives in order
to set standards of
quality and safety
for human tissues
and cells intended
for human medical treatments
and to ensure a high level
of protection of human health.
While the directives apply to
hermatopoetic peripheral blood,
umbilical cord blood, bone
marrow stem cells, fetal tissues
and cells, embryonic stem
cells, I'll specifically focus
on reproductive cells in my talk.